Correlation Between Krebs Biochemicals and Cambridge Technology

Can any of the company-specific risk be diversified away by investing in both Krebs Biochemicals and Cambridge Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krebs Biochemicals and Cambridge Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Krebs Biochemicals and and Cambridge Technology Enterprises, you can compare the effects of market volatilities on Krebs Biochemicals and Cambridge Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krebs Biochemicals with a short position of Cambridge Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krebs Biochemicals and Cambridge Technology.

Diversification Opportunities for Krebs Biochemicals and Cambridge Technology

0.03

Correlation Coefficient

Krebs Biochemicals  Cambridge Technology

Significant diversification

The 3 months correlation between Krebs and Cambridge is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Krebs Biochemicals and and Cambridge Technology Enterpris in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cambridge Technology and Krebs Biochemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krebs Biochemicals and are associated (or correlated) with Cambridge Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cambridge Technology has no effect on the direction of Krebs Biochemicals i.e., Krebs Biochemicals and Cambridge Technology go up and down completely randomly.

Pair Corralation between Krebs Biochemicals and Cambridge Technology

Assuming the 90 days trading horizon Krebs Biochemicals and is expected to generate 1.57 times more return on investment than Cambridge Technology. However, Krebs Biochemicals is 1.57 times more volatile than Cambridge Technology Enterprises. It trades about 0.07 of its potential returns per unit of risk. Cambridge Technology Enterprises is currently generating about -0.03 per unit of risk. If you would invest  7,402  in Krebs Biochemicals and on September 30, 2024 and sell it today you would earn a total of  2,194  from holding Krebs Biochemicals and or generate 29.64% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Krebs Biochemicals and  vs.  Cambridge Technology Enterpris

Krebs Biochemicals and

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Krebs Biochemicals and are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady fundamental drivers, Krebs Biochemicals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Cambridge Technology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cambridge Technology Enterprises has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Cambridge Technology is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Krebs Biochemicals and Cambridge Technology

The main advantage of trading using opposite Krebs Biochemicals and Cambridge Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krebs Biochemicals position performs unexpectedly, Cambridge Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cambridge Technology will offset losses from the drop in Cambridge Technology's long position.

The idea behind Krebs Biochemicals and and Cambridge Technology Enterprises pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.